Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000303
Chunk: 99

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 99
---
 or deemed made;

(vii) Any material
provision of any Transaction Document, at any time after its execution and delivery and for any reason other than as expressly permitted
hereunder or thereunder, ceases to be in full force and effect; or the Company or any other Person contests in writing the validity or
enforceability of any provision of any Transaction Document; or the Company denies in writing that it has any or further liability or
obligation under any Transaction Document, or purports in writing to revoke, terminate (other than in line with the relevant termination
provisions) or rescind any Transaction Document;

(viii) the Company
uses the proceeds of the issuance of this Note, whether directly or indirectly, and whether immediately, incidentally or ultimately, to
purchase or carry margin stock (within the meaning of Regulations T, U and X the Federal Reserve Board, as in effect from time to time
and all official rulings and interpretations thereunder or thereof), or to extend credit to others for the purpose of purchasing or carrying
margin stock or to refund indebtedness originally incurred for such purpose; or

(ix) Any Event of
Default (as defined in any Other Notes or in any Transaction Document other than this Note) occurs with respect to any Other Notes, or
any breach of any material term of any other debenture, note, or instrument held by the Holder in the Company or any agreement between
or among the Company and the Holder resulting in a right by the Holder to accelerate the maturity of such indebtedness in an amount in
excess of $100,000; or

(x) The Company
shall fail to observe or perform any material covenant, agreement or warranty contained in, or otherwise commit any material breach or
default of any provision of this Note (except as may be covered by Section (2)(a)(i) through (2)(a)(x) hereof) or any other Transaction
Document, which is not cured or remedied within the time prescribed therein, or if no time is prescribed, withing ten (10) Business Days.

(b) During the time that any
portion of this Note is outstanding, if any Event of Default has occurred and is continuing, (other than an event with respect to the
Company described in Section (2)(a)(ii)), the full unpaid Principal amount of this Note, together with interest and other amounts owing
in respect thereof, to the date of acceleration shall become at the Holder’s election given by notice pursuant to